635P ARCHES - The role of androgen deprivation therapy (ADT) with enzalutamide (ENZA) or placebo (PBO) in metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analyses of efficacy by baseline prostate-specific antigen (PSA) levels

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Alcaraz, A; Szmulewitz, RZ; Shore, N; Crawford, ED; Petrylak, DP; Holzbeierlein, J; Villers, A; Azad, AA; Alekseev, B; Iguchi, T; Gomez-Veiga, F; Rosbrook, B; Sugg, J; Haas, GP; Stenzl, A; Armstrong, AJ

Published Date

  • September 2020

Published In

Volume / Issue

  • 31 /

Start / End Page

  • S523 - S524

Published By

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1016/j.annonc.2020.08.894